title: Serum leptin levels in patients with liver cirrhosis and chronic viral hepatitis.
abstract: BACKGROUND
  The aim of the present study was to investigate serum leptin levels in relation to anthropometric features in patients with liver cirrhosis (LC) and chronic viral hepatitis (CVH), and to determine the effect of the severity and aetiology of the LC on serum leptin levels.
  
  
  METHODS
  Forty-nine patients with LC, 32 patients with CVH and 69 control subjects were age, body mass index (BMI) and sex-matched and included in the study. Plasma glucose, serum leptin and insulin levels were determined. Insulin resistance was assessed using homoeostasis model assessment (HOMA). Body composition was estimated by skinfold thickness.
  
  
  RESULTS
  Female patients with Child-A LC had higher levels of leptin, and female and male patients with Child-A LC had higher absolute leptin (leptin/BFM) levels compared to patients with Child-C LC and control subjects. Serum leptin levels of the patients with alcohol LC were higher than the control subjects, but the absolute leptin levels were comparable. When alcoholic and post-viral hepatitis cirrhotic patients were compared with each other on an aetiologic basis, there was no significant difference between them in leptin and absolute leptin levels. There were significant correlations between leptin and BMI, body fat percentage (BFP), BFM (body fat mass) in all three groups in both sexes.
  
  
  CONCLUSIONS
  These data suggest that the physiologic correlations among serum leptin level, sex, BMI and BFM were well preserved in patients with chronic liver disease. Patients with alcohol LC had higher leptin levels. In early stages of liver disease, leptin levels and absolute leptin levels are higher than in normal subjects. However, in advanced stages of the disease the significant decline in leptin levels and similar levels of leptin expressed in relation to BFM compared to control subjects predominantly represent the expression of fat mass.
authors.affiliation: Dokuz Eylül University Medical School, Dept. of Internal Medicine, Division of Endocrinology, Inciralti, Turkey. comlekci@deu.edu.tr
authors.forename: A
authors.initials: A
authors.lastname: Comlekci
authors.forename: H
authors.initials: H
authors.lastname: Akpinar
authors.forename: S
authors.initials: S
authors.lastname: Yesil
authors.forename: I
authors.initials: I
authors.lastname: Okan
authors.forename: E
authors.initials: E
authors.lastname: Ellidokuz
authors.forename: A
authors.initials: A
authors.lastname: Okan
authors.forename: G
authors.initials: G
authors.lastname: Ersoz
authors.forename: E
authors.initials: E
authors.lastname: Tankurt
authors.forename: Y
authors.initials: Y
authors.lastname: Batur
mesh_terms: D000328:Adult; D000368:Aged; D000886:Anthropometry; D001786:Blood Glucose / Q000378:metabolism; D015992:Body Mass Index; D005260:Female; D006521:Hepatitis, Chronic / Q000097:blood*; D006525:Hepatitis, Viral, Human / Q000097:blood*; D006801:Humans; D007004:Hypoglycemic Agents / Q000097:blood; D007328:Insulin / Q000097:blood; D020738:Leptin / Q000097:blood*; D008103:Liver Cirrhosis / Q000097:blood* / Q000209:etiology; D008104:Liver Cirrhosis, Alcoholic / Q000097:blood; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D012720:Severity of Illness Index
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D020738:Leptin